KSNM/KSID/KOSHIC Guidance for Nuclear Medicine Department Against the Coronavirus Disease 2019 (COVID-19) Pandemic

Bang, Ji In; Lee, Ho‐Young; Cho, Young Seok; Choi, Hongyoon; Chong, Ari; Eo, Jae Sun; Kim, Ji Young; Kim, Tae Sung; Kwon, Ho Jang; Lee, Eun Jeong; Lee, Eun Seong; Park, Hye Lim; Park, Soo Bin; Shim, Hye Kyung; Song, Byung Seop; Yoo, Ik Dong; Lee, Kyung Jae; Lee, Hong Jae; Han, Su Ha; Lee, Jin Seo; Park, Sungha; Kim, Sung Hoon

doi:10.1007/s13139-020-00660-9

Cited by 2 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These were replaced by a guideline provided by the Korean Society of NM. 7 ) No COVID-19 patients have been examined at the NM department of CNUH and no NM staff members have developed COVID-19 to date. Vaccination for NM staff members began in March 2021.…”

Section: Introductionmentioning

confidence: 99%

Impact of COVID-19 on Nuclear Medicine in Asia

Bom

Pascual²,

Choudhury

et al. 2022

Seminars in Nuclear Medicine

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) was first detected in China in late 2019 and rapidly spread to nearby Asian countries in early 2020. Outbreaks occurred differently in each country and affected nuclear medicine (NM) practice significantly even before the COVID-19 pandemic. The Asian NM community has worked together from the beginning of the pandemic. Fortunately, the Asian Regional Cooperative Council for Nuclear Medicine (ARCCNM) annual general meeting and Asia Nuclear Medicine Board (ANMB) examination were held in Manila from January 28 to February 2, 2020; these were the last face-to-face events of these organizations to date. Members shared information about COVID-19 at the conference, and through online means afterwards. Web-based surveys performed from March to April 2020 for the ARCCNM and ANMB communities showed a significant reduction of NM practice and supply of radioisotopes (RI) at the beginning of the COVID-19 pandemic. A follow-up survey in March to April 2021 clearly showed the recovery of both NM practice and RI supplies. The pattern of recovery is variable according to institutions and countries. Herein, we have reported the case-in-point operational histories of four representative institutions in the East, Southeast, South, and West Asia. The second outbreak in India is ongoing on a worrisome scale. Various communications and educational sessions were actively performed online in the Asian NM community during the pandemic.

show abstract

Section: Introductionmentioning

confidence: 99%

Impact of COVID-19 on Nuclear Medicine in Asia

Bom

Pascual²,

Choudhury

et al. 2022

Seminars in Nuclear Medicine

View full text Add to dashboard Cite

show abstract

“…For the pulmonary function test (PFT), some countries recommend that the documented negative swab test result be presented 48-72 h prior to the test [20]; this can also be considered before the ventilation scan according to the circumstances. There are guidance documents for the protection of health care workers in the nuclear medicine procedure from COVID-19 infection [21][22][23]. Guidelines for PFT can also be referred to [20].…”

mentioning

confidence: 99%

In the COVID-19 Era, Is It OK to Perform a Perfusion-Only SPECT/CT for the Diagnosis of Pulmonary Embolism?

Suh

2022

Nucl Med Mol Imaging

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is a global and international public health emergency. The COVID-19 pandemic is having a profound impact on patient care and nuclear medicine practice, especially lung ventilation scans. There is still a lack of evidence whether the lung ventilation scan should be considered as an aerosol-generating procedure. However, since infection from COVID-19 is mainly transmitted by respiratory droplets and close contact, both test personnel and patients are at risk of transmission of COVID-19 during lung ventilation scans. In the inhalation procedure, the patient releases respiratory fluids in the form of droplets, which may carry the virus and transmit infection. For this reason, several recent papers suggest that a ventilation scan can be omitted and it can be replaced with perfusion-only single-photon emission tomography (SPECT)/computed tomography (CT) for the diagnosis of pulmonary embolism [1][2][3].With the advent of hybrid SPECT/CT, it is possible to evaluate the pulmonary perfusion status in three-dimensional space, and when combined with the segmental anatomical information of each patient determined based on the CT scan, it offers a more accurate diagnosis [4]. Co-registered low-dose CT scans can directly assess the structural abnormality of the airways, lung parenchyma, and pleura, and areas with reduced perfusion without corresponding structural abnormalities are likely indicative of pulmonary embolism. Several studies have reported the diagnostic performance of perfusion-only SPECT/CT in the diagnosis of pulmonary thromboembolic disease [5][6][7][8][9][10][11] (Table 1). In common, perfusion-only SPECT/CT showed high sensitivity ranging from 88 to 100%, and a high negative predictive value of 91-100%. However, the specificity was reported to vary from as low as * Minseok Suh

show abstract

KSNM/KSID/KOSHIC Guidance for Nuclear Medicine Department Against the Coronavirus Disease 2019 (COVID-19) Pandemic

Cited by 2 publications

References 6 publications

Impact of COVID-19 on Nuclear Medicine in Asia

Impact of COVID-19 on Nuclear Medicine in Asia

In the COVID-19 Era, Is It OK to Perform a Perfusion-Only SPECT/CT for the Diagnosis of Pulmonary Embolism?

Contact Info

Product

Resources

About